Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP433511.RAmSXEa1yNCQ8a0R5A0VaXZdTYYJFbfwicWVRGO7uJJfE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP433511.RAmSXEa1yNCQ8a0R5A0VaXZdTYYJFbfwicWVRGO7uJJfE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP433511.RAmSXEa1yNCQ8a0R5A0VaXZdTYYJFbfwicWVRGO7uJJfE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP433511.RAmSXEa1yNCQ8a0R5A0VaXZdTYYJFbfwicWVRGO7uJJfE130_provenance.
- NP433511.RAmSXEa1yNCQ8a0R5A0VaXZdTYYJFbfwicWVRGO7uJJfE130_assertion description "[PTPN12 interacts with the same T cell activation accessory molecules, Grb2 and Csk kinase, as the Graves' disease (GD) associated PTPN22 encoded lymphoid tyrosine phosphatase (LYP) molecule and also plays a key role in T cell receptor signalling, leading to the hypothesis that it too may be involved in GD susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433511.RAmSXEa1yNCQ8a0R5A0VaXZdTYYJFbfwicWVRGO7uJJfE130_provenance.
- NP433511.RAmSXEa1yNCQ8a0R5A0VaXZdTYYJFbfwicWVRGO7uJJfE130_assertion evidence source_evidence_literature NP433511.RAmSXEa1yNCQ8a0R5A0VaXZdTYYJFbfwicWVRGO7uJJfE130_provenance.
- NP433511.RAmSXEa1yNCQ8a0R5A0VaXZdTYYJFbfwicWVRGO7uJJfE130_assertion SIO_000772 17608818 NP433511.RAmSXEa1yNCQ8a0R5A0VaXZdTYYJFbfwicWVRGO7uJJfE130_provenance.
- NP433511.RAmSXEa1yNCQ8a0R5A0VaXZdTYYJFbfwicWVRGO7uJJfE130_assertion wasDerivedFrom befree-20150227 NP433511.RAmSXEa1yNCQ8a0R5A0VaXZdTYYJFbfwicWVRGO7uJJfE130_provenance.
- NP433511.RAmSXEa1yNCQ8a0R5A0VaXZdTYYJFbfwicWVRGO7uJJfE130_assertion wasGeneratedBy ECO_0000203 NP433511.RAmSXEa1yNCQ8a0R5A0VaXZdTYYJFbfwicWVRGO7uJJfE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP433511.RAmSXEa1yNCQ8a0R5A0VaXZdTYYJFbfwicWVRGO7uJJfE130_provenance.